Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Return on Assets (2021 - 2023)

Historic Return on Assets for Immuneering (IMRX) over the last 4 years, with Q3 2024 value amounting to 0.21%.

  • Immuneering's Return on Assets rose 2300.0% to 0.21% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.21%, marking a year-over-year increase of 2300.0%. This contributed to the annual value of 0.49% for FY2023, which is 1400.0% down from last year.
  • As of Q3 2024, Immuneering's Return on Assets stood at 0.21%, which was up 2300.0% from 0.35% recorded in Q2 2024.
  • In the past 5 years, Immuneering's Return on Assets registered a high of 0.2% during Q4 2021, and its lowest value of 0.51% during Q4 2023.
  • Moreover, its 4-year median value for Return on Assets was 0.35% (2022), whereas its average is 0.35%.
  • As far as peak fluctuations go, Immuneering's Return on Assets plummeted by -2000bps in 2023, and later surged by 2300bps in 2024.
  • Over the past 4 years, Immuneering's Return on Assets (Quarter) stood at 0.2% in 2021, then plummeted by -94bps to 0.4% in 2022, then dropped by -28bps to 0.51% in 2023, then skyrocketed by 58bps to 0.21% in 2024.
  • Its Return on Assets was 0.21% in Q3 2024, compared to 0.35% in Q2 2024 and 0.43% in Q1 2024.